drugset / Trial / NCT06405243
Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the study is to compare and assess the efficacy of combined letrozole with myoinositol, chromium, or L-arginine in infertile women with PCOS. This study will help in the investigation of alternative therapeutic modalities for fertility improvement in polycystic ovarian syndrome
Timeline
- Start
- 2024-06-30
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARGININE | Small molecule | 500 mg | — |
| Subject | Chromium | Other / unclassified | 281.569 ug | — |
| Subject | Letrozole | Other / unclassified | 2.5 mg | — |
| Subject | Myo-inositol | Small molecule | 2 g | — |